flow trial semaglutide kidney outcomes Get With the FLOW! in: News Volume 16 Issue 8 (2024) FLOWing with the SemagluTIDE —

This ensures your treatment remains effective in the long term

Due to its mechanism of action and teratogenic effect, it is contraindicated in acute liver diseases and pregnancy (Depass and Weaver, 2011)

Simizu, S., Suzuki, T., Muroi, M., Lai, N

Keren-Shaul et al

Table of Contents Understanding Wegovy and Its Effects on the Body Wegovy (semaglutide 2.4mg) is a prescription medication licensed in the UK for weight management in adults with obesity (BMI 30kg/m) or those who are overweight (BMI 27kg/m) with weight-related health conditions such as pre-diabetes, type 2 diabetes, hypertension, or dyslipidaemia

The molecular switch controlling the opposing functions of COX7A1remains unknown, limiting its therapeutic exploitation